{
    "symbol": "CAAS",
    "quarter": 3,
    "year": 2022,
    "date": "2022-11-14 13:06:05",
    "content": " Research and development expenses, R&D, increased by 66.7% year-over-year to $9.5 million in the 2022 third quarter as we grew our investments in new product development and to further build our technology base. Higher gross profit, stricter cost controls and higher other income helped generate income from operations of $4.9 million in the third quarter of 2022 compared to $0.6 million in the third quarter of 2021. Net cash provided by operating activities was $31.7 million in the first 9 months of 2022 compared with net cash used in operating activities of $5.9 million in the first 9 months of 2021. EPS net sales were $44.8 million or 32.7% of net sales compared with $29.4 million or 27.2% of net sales in the third quarter of 2021. Net product sales in North America decreased by 4.8% to $29.5 million due primarily to changes in the product mix compared with $31 million for the same quarter in 2021. Research and development, R&D, increased by 66.7% to $9.5 million in the third quarter of 2022 compared to $5.7 million in the third quarter of 2021. Other income was $0.7 million in the third quarter of 2022 compared with $2.4 million in the third quarter of 2021, primarily due to lower government subsidies received in the third quarter of 2022. Net financial income was $4.8 million compared with net financial expense of $0.8 million in the third quarter of 2021, mainly due to the foreign exchange volatility of the U.S. dollar against the RMB and the Brazilian real. Income before income tax expenses and equity in earnings of accelerated companies was $10 million in the third quarter of 2022 compared to income before income tax expenses and equity in earnings of affiliated companies of $1.9 million in the third quarter of 2021. Income tax expense was $0.9 million in the third quarter of 2022 compared to an income tax expense of $2.4 million for the third quarter of 2021 which was mainly due to the valuation allowance recognized in the third quarter of 2021. Net income attributable to parent company's common shareholders was $7.5 million in the third quarter of 2022 compared to a net loss attributable to parent company's common shareholders of $0.3 million in the third quarter of 2021. Net cash provided by operating activities was $31.7 million in the first 9 months of 2022 compared with net cash used in operating activities of $5.9 million in the first 9 months of 2021."
}